Saratoga County Supreme Court Justice Dianne Freestone recently ruled that the City of Saratoga Springs previously violated ...

The chair of the city’s Republican Committee is hailing a judge’s decision that ruled the City Council violated the state’s Open Meeting Law as a victory for government transparency, even though it ...

There are new signs up around Saratoga Springs warning of pedestrians crossing. There is a sign warning drivers of pedestrian crossings near the Code Blue shelter on Route 9, according to the city ...

Shares of Regeneron Pharmaceuticals Inc. REGN shed 1.75% to $828.84 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0.28% ...

On Monday, TD Cowen reaffirmed its confidence in shares of Regeneron (NASDAQ:REGN) Pharmaceuticals (NASDAQ: REGN) shares by maintaining a Buy rating and a price target of $1,230.00. The ...

Regeneron Pharmaceuticals had a return on equity of 16.88% and a net margin of 33.61%. The business had revenue of $3.55 billion for the quarter, compared to analyst estimates of $3.38 billion.

In another twist in the ongoing saga to permanently fill an empty seat on the Saratoga Springs city council, city Republicans are claiming Democrats have failed to nominate a candidate for January ...

The Saratoga Springs High School varsity field hockey team defeated Bethlehem, 1-0, in the Section 2 Class A Championship-Semifinals, on Thursday, Oct. 31, 2024, at Bethlehem High School, in ...

In addition, please check the fund’s top five holdings to know its best picks in 2024. Baron Health Care Fund highlighted stocks like Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) in the Q3 2024 ...

Barclays lowered the firm’s price target on Regeneron (REGN) to $1,065 from $1,080 and keeps an Overweight rating on the shares post the Q3 report. The firm says recent pressure on Regeneron ...

Shares of Regeneron (NASDAQ:REGN) lost nearly a third of their value since my previous update where I said that the stock is near the high end of the valuation range that I deemed appropriate to ...